| |
Annual Advancement in PRRS Research Award
Despite
years of hard work by scientists, researchers, practicing veterinarians,
pork producers, animal health companies, and others, Porcine Reproductive and Respiratory Syndrome (PRRS) remains a
costly, frustrating challenge to the global swine industry.
At Boehringer Ingelheim Vetmedica, Inc., we're furthering our commitment to
research efforts for PRRS control.
Each year we issue a call for proposals for the Annual Boehringer
Ingelheim Advancement in PRRS Research Award Program. The deadline for submissions are January 1 of each year.
Boehringer Ingelheim will provide three U.S. $25,000 awards to the winning proposals for PRRS research in the NAFTA region.
Candidates included graduate students, academic researchers, company or private
researchers, and practicing veterinarians.
The 2009 Advancement in PRRS Research Awards recipients will be announced at the American Association of Swine Veterinarians Conference in Dallas, Texas.
Objective: Examine practical methods of controlling,
managing, and possibly eradicating the PRRS virus.
The independent PRRS Research Review Board (PRRB)
Members include:
- Rodney "Butch" Baker, DVM, Iowa State University, Ames, Iowa
- Luc Dufresne, DVM, Seaboard Farms, Shawnee Mission, Kansas
- Locke Karriker, DVM, MS, Iowa State University, Ames, Iowa
- Tim Loula, DVM, Swine Vet Center, P.A., St. Peter, Minnesota
- Bill Mengeling, DVM, PhD, Diplo. ACVM, Iowa State University, Ames, Iowa
- Daryl Olsen, DVM, AMVC, Audubon, Iowa
Once the three winning year-long research projects are completed
and submitted for peer review, PRRB will conduct a second evaluation.
Upon acceptance for
publication of his or her findings, the first place award recipient will
receive an additional U.S. $5,000; second place, $3,000; and third
place, $1,000.
Our independent PRRS Research Review Board members look forward to reviewing
your proposal; please submit your proposal at your earliest convenience by
mail or electronically to:
Boehringer
Ingelheim Vetmedica, Inc.
Attn: Trudy Luther
The Advancement in PRRS Research Award
5506 Corporate Dr., Suite 1600
St. Joseph, MO 64507-7752
trudy.luther@boehringer-ingelheim.com
For complete proposal details visit (http://www.PRRSResearch.com/instructions) the instructions page.
About Boehringer Ingelheim Vetmedica, Inc.
The Boehringer Ingelheim group is one of the world’s 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, it operates globally with 135 affiliates in 47 countries and approximately 39,800 employees. Since it was founded in 1885, the family-owned company has been committed to researching, developing, manufacturing and marketing novel products of high therapeutic value for human and veterinary medicine.
In 2007, Boehringer Ingelheim posted net sales of US $15.0 billion (10.9 billion euro) while spending approximately one-fifth of net sales in its largest business segment, Prescription Medicines, on research and development.
|
